Treatment with cemsidomide resulted in notable responses at multiple dose levels for patients with multiple myeloma ...

Treatment with an Enhertu regimen significantly improved pathologic complete responses for patients with high-risk ...

After 30 years with breast cancer, I urge others to pause, reflect and choose care based on long-term wellbeing, not fear or ...

All the while, she bonded easily with patients and became their go-to person as they went through the expected stages of ...

Dr. Armine Smith discusses the importance of personalized therapeutic approaches for the treatment of urologic cancers, such ...

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

Treatment with givinostat has received fast track designation from the United States Food and Drug Administration for ...

She wore a variety of bright sneakers and occasionally did a cha-cha-cha in them. Her laughter was contagious. Patients ...

Dr. Cathy Eng discusses data that led to the FDA approval of Braftovi and Erbitux plus chemo for metastatic colorectal cancer ...

First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and ...

Discrepancies between patients' experiences and friends' lives can strain relationships, highlighting the need for ...

Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment ...